Identical twin given six months to live says leaving sister is ‘unthinkable’
Identical Twin Given Six Months to Live Describes Separation from Sister as 'Unthinkable'
Identical twin given six months to live - Caitlin Leggett, a 24-year-old from Cardiff, has been told she has six months to live after a recurrence of acute myeloid leukaemia (AML), a rapid-onset blood cancer. The identical twin given six months to live has become a central figure in her family's fight for survival, as she grapples with the emotional weight of being separated from her twin sister, Grace. The sisters, who have shared every life experience since university, now face an uncertain future together, with Caitlin’s condition casting a shadow over their bond.
The Journey from Health to Uncertainty
Caitlin’s journey began in April 2025 with a persistent rash, the first sign of her illness. Initially dismissed as a minor issue, the symptoms eventually led to a critical diagnosis of AML. As an identical twin given six months to live, Caitlin’s case has been a dramatic twist for her family, who had long believed the twins were fraternal due to their separate amniotic sac development. This assumption was overturned when DNA markers confirmed their identical status, deepening the emotional impact of the diagnosis.
Grace, Caitlin’s constant support, expressed the heartbreak of the situation. "Being twins, you’re not supposed to have one twin not be there. It’s unthinkable," she said, highlighting the twins’ inseparable connection. Caitlin shared a similar sentiment, stating, "We’ve gone through life together, and I don’t want our story to end here." The emotional toll of the relapse has been profound, with the twins now facing the possibility of being split apart for treatment.
Family and Global Hope for Treatment
Following Caitlin’s relapse, the family was evaluated as potential donors for a stem cell transplant. Grace was initially the ideal match due to her identical DNA. However, this changed when the cancer returned, making her ineligible. Caitlin’s condition now relies on finding a donor from a specialized register, as the identical twin given six months to live is no longer able to rely on her sister’s support. International options, including CAR-T cell therapy, are now being explored to offer new hope.
Caitlin’s treatment plan, which included a clinical trial in Manchester using menin inhibitors, brought her to a temporary remission. Yet, the identical twin given six months to live remained anxious about the future. Her doctors warned that the prognosis might not be permanent, prompting her to advocate for extended monitoring. "I wasn’t too happy about going straight to three-month intervals," she explained, emphasizing her determination to stay vigilant.
With the twins’ bond tested by illness, Caitlin’s situation has sparked discussions about the importance of donor registries. According to DKMS, a UK blood cancer charity, over 2,000 individuals require stem cell transplants annually, but only 7% of the eligible population is registered. The identical twin given six months to live now symbolizes the urgent need for more donors, especially as her condition remains a challenge for her family and medical team.
Challenges and Determination in the Face of Adversity
Caitlin’s experience highlights the unpredictability of AML, which can rapidly progress despite initial remission. The identical twin given six months to live has become a beacon of resilience, as she continues to search for life-saving therapies abroad. Fundraising efforts are underway to cover the £500,000 cost of international treatment, with the sisters relying on community support to sustain their fight. "I’m not giving up," Caitlin said. "I’m still here, and I’m still fighting for my sister."
As Caitlin faces the next phase of treatment, her story underscores the emotional and medical complexities of being an identical twin given six months to live. While her condition is a personal struggle, it also serves as a reminder of the challenges many patients face in accessing adequate care. The twins’ journey, from university days to a life-threatening diagnosis, continues to inspire those who follow their story, offering a powerful testament to the strength of family and the hope of medical innovation.